161 related articles for article (PubMed ID: 38892457)
1. Generalized Pustular Psoriasis and Systemic Organ Dysfunctions.
Teshima R; Saito-Sasaki N; Sawada Y
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892457
[TBL] [Abstract][Full Text] [Related]
2. Generalized pustular psoriasis: practical recommendations for Spanish primary care and emergency physicians.
Rivera-Diaz R; Epelde F; Heras-Hitos JA; Martínez Virto AM; Dávalos Marin AJ; Senán Sanz MR; Carrascosa JM
Postgrad Med; 2023 Nov; 135(8):766-774. PubMed ID: 38019177
[TBL] [Abstract][Full Text] [Related]
3. Clinical Course and Characteristics of Generalized Pustular Psoriasis.
Choon SE; Navarini AA; Pinter A
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):21-29. PubMed ID: 35061227
[TBL] [Abstract][Full Text] [Related]
4. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
Menter A; Van Voorhees AS; Hsu S
Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
[TBL] [Abstract][Full Text] [Related]
5. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion.
Bachelez H; Barker J; Burden AD; Navarini AA; Krueger JG
Expert Rev Clin Immunol; 2022 Oct; 18(10):1033-1047. PubMed ID: 36062811
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of generalized pustular psoriasis.
Iizuka H; Takahashi H; Ishida-Yamamoto A
Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S55-9. PubMed ID: 12677433
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of Generalized Pustular Psoriasis.
Marrakchi S; Puig L
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):13-19. PubMed ID: 35061228
[TBL] [Abstract][Full Text] [Related]
8. Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment.
Rivera-Díaz R; Daudén E; Carrascosa JM; Cueva P; Puig L
Dermatol Ther (Heidelb); 2023 Mar; 13(3):673-688. PubMed ID: 36635445
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases.
Haskamp S; Bruns H; Hahn M; Hoffmann M; Gregor A; Löhr S; Hahn J; Schauer C; Ringer M; Flamann C; Frey B; Lesner A; Thiel CT; Ekici AB; von Hörsten S; Aßmann G; Riepe C; Euler M; Schäkel K; Philipp S; Prinz JC; Mößner R; Kersting F; Sticherling M; Sefiani A; Lyahyai J; Sondermann W; Oji V; Schulz P; Wilsmann-Theis D; Sticht H; Schett G; Reis A; Uebe S; Frey S; Hüffmeier U
Am J Hum Genet; 2020 Sep; 107(3):527-538. PubMed ID: 32758447
[TBL] [Abstract][Full Text] [Related]
10. A brief guide to pustular psoriasis for primary care providers.
Crowley JJ; Pariser DM; Yamauchi PS
Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
[TBL] [Abstract][Full Text] [Related]
11. A review of disease burden and clinical management for generalized pustular psoriasis in China.
Lu J; Shi Y
Expert Rev Clin Immunol; 2022 Oct; 18(10):1023-1032. PubMed ID: 36040447
[TBL] [Abstract][Full Text] [Related]
12. Clinical Disease Measures in Generalized Pustular Psoriasis.
Burden AD; Choon SE; Gottlieb AB; Navarini AA; Warren RB
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):39-50. PubMed ID: 35061231
[TBL] [Abstract][Full Text] [Related]
13. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis.
Johnston A; Xing X; Wolterink L; Barnes DH; Yin Z; Reingold L; Kahlenberg JM; Harms PW; Gudjonsson JE
J Allergy Clin Immunol; 2017 Jul; 140(1):109-120. PubMed ID: 28043870
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.
Wen P; Liu C; Wang T; Jiang X; Wang P; Wang S
Front Immunol; 2024; 15():1338285. PubMed ID: 38464535
[TBL] [Abstract][Full Text] [Related]
15. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.
Hawkes JE; Visvanathan S; Krueger JG
Front Immunol; 2023; 14():1292941. PubMed ID: 38077370
[TBL] [Abstract][Full Text] [Related]
16. Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: Should they be the same or different entities?
Chularojanamontri L; Rattanakorn K; Julanon N; Chuamanochan M; Griffiths CEM
Exp Dermatol; 2023 Aug; 32(8):1235-1245. PubMed ID: 37057764
[TBL] [Abstract][Full Text] [Related]
17. Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.
Boehner A; Navarini AA; Eyerich K
Exp Dermatol; 2018 Oct; 27(10):1067-1077. PubMed ID: 29852521
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal and hepatic manifestations in patients with generalised pustular psoriasis.
Lim LY; Oon HH
Exp Dermatol; 2023 Aug; 32(8):1246-1252. PubMed ID: 36779689
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal bleeding with severe mucosal involvement in a patient with generalized pustular psoriasis without IL36RN mutation.
Komatsuda S; Kamata M; Chijiwa C; Namiki K; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Abe K; Yamamoto T; Aozasa N; Sugiura K; Tada Y
J Dermatol; 2019 Jan; 46(1):73-75. PubMed ID: 30474867
[TBL] [Abstract][Full Text] [Related]
20. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
